Vasomune Therapeutics Inc., a clinical-stage biopharmaceutical company focused on the development of AV-001 for the treatment ...

The burden of babesiosis disease was significantly worse among patients with vs without immunocompromising conditions.

Global Virus Network warns of potential H5N1 pandemic, citing outbreaks in US dairy cows and humans. The virus, primarily ...

Patients suffering from long COVID may exhibit persistent inflammation in the heart and lungs for up to a year following SARS ...

Raymond Osarogiagbon, MD, highlights the potential benefits of increasing screening rates for patients diagnosed with lung cancer and the broader US health care system.

Despite widespread vaccine availability and improved treatment strategies, certain patients with SARDs remain highly vulnerable to severe COVID-19 outcomes.